Clinical Influence of Ploidy and Cancer Stem Cells and Other Parameters in Stage IV Colorectal Cancer

被引:3
作者
Polyzos, Konstantinos A. [1 ]
Karadima, Maria L. [2 ]
Kosma, Aikaterini C. [3 ]
Lazaris, Andreas [1 ]
Kavantzas, Nikolaos [4 ]
Tsavaris, Nikolas [2 ]
机构
[1] Univ Athens, Dept Internal Med, Fac Med, Athens, Greece
[2] Univ Athens, Dept Pathophysiol, Fac Med, Athens, Greece
[3] Gen Hosp Nikaia, Div Internal Med 2, Piraeus, Greece
[4] Univ Athens, Dept Pathol, Fac Med, Athens, Greece
来源
IN VIVO | 2019年 / 33卷 / 01期
关键词
Colorectal cancer; prognosis; stem cells; ploidy; EXPRESSION; SURVIVAL;
D O I
10.21873/invivo.11467
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background/Aim: The aim of the present study was the evaluation of the influence of cancer stem cells and other parameters in stage IV colorectal cancer patients. Materials and Methods: One hundred patients were retrospectively included in the study and 24 variables were examined for their relation with response to treatment and survival. Results: A low ploidy score in the histology of colorectal cancer was associated with improvement of performance status and response to therapy. No significant correlations between the percentage of cancer stem cells from the same tissue and the remaining clinical parameters was revealed. In the multivariate analysis of all the examined parameters in Cox models, independent unfavorable prognostic factors were increased ploidy score, existence of bone metastases, use of epoetin, and existence of side-effects such as anorexia, mucositis, and weight loss. Conclusion: Our findings emphasize on the prognostic role of ploidy in advanced colorectal cancer, but further analysis is required to evaluate the role of cancer stem cells.
引用
收藏
页码:245 / 249
页数:5
相关论文
共 18 条
  • [11] CD133-positive tumor cell content is a predictor of early recurrence in colorectal cancer
    Lim, Sung Hee
    Jang, Jiryeon
    Park, Joon Oh
    Kim, Kyoung-Mee
    Kim, Seung Tae
    Park, Young Suk
    Lee, Jeeyun
    Kim, Hee Cheol
    [J]. JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2014, 5 (06) : 447 - 456
  • [12] Predictors of short-term survival and progression to chemotherapy in patients with advanced colorectal cancer treated with 5-fluorouracil-based regimens
    Massacesi, C
    Pistilli, B
    Valeri, M
    Lippe, P
    Rocchi, MBL
    Cellerino, R
    Piga, A
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2002, 25 (02): : 140 - 148
  • [13] Fibronectin extra domain A (EDA) sustains CD133+/CD44+ subpopulation of colorectal cancer cells
    Ou, Juanjuan
    Deng, Jia
    Wei, Xing
    Xie, Ganfeng
    Zhou, Rongbin
    Yu, Liqing
    Liang, Houjie
    [J]. STEM CELL RESEARCH, 2013, 11 (02) : 820 - 833
  • [14] CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors
    Shmelkov, Sergey V.
    Butler, Jason M.
    Hooper, Andrea T.
    Hormigo, Adilia
    Kushner, Jared
    Milde, Till
    St. Clair, Ryan
    Baljevic, Muhamed
    White, Ian
    Jin, David K.
    Chadburn, Amy
    Murphy, Andrew J.
    Valenzuela, David M.
    Gale, Nicholas W.
    Thurston, Gavin
    Yancopoulos, George D.
    D'Angelica, Michael
    Kemeny, Nancy
    Lyden, David
    Rafii, Shahin
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2008, 118 (06) : 2111 - 2120
  • [15] Personalizing Survival Predictions in Advanced Colorectal Cancer: The ARCAD Nomogram Project
    Sjoquist, Katrin M.
    Renfro, Lindsay A.
    Simes, R. John
    Tebbutt, Niall C.
    Clarke, Stephen
    Seymour, Matthew T.
    Adams, Richard
    Maughan, Timothy S.
    Saltz, Leonard
    Goldberg, Richard M.
    Schmoll, Hans-Joachim
    Van Cutsem, Eric
    Douillard, Jean-Yves
    Hoff, Paulo M.
    Hecht, Joel Randolph
    Tournigand, Christophe
    Punt, Cornelis J. A.
    Koopman, Miriam
    Hurwitz, Herbert
    Heinemann, Volker
    Zalcberg, John R.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2018, 110 (06): : 638 - 648
  • [16] Survival in patients with stage IV noncardia gastric cancer - the influence of DNA ploidy and Helicobacter Pylori infection
    Syrios, John
    Sougioultzis, Stavros
    Xynos, Ioannis D.
    Kavantzas, Nikolaos
    Kosmas, Christos
    Agrogiannis, George
    Griniatsos, John
    Karavokyros, Ioannis
    Pikoulis, Emmanouil
    Patsouris, Efstratios S.
    Tsavaris, Nikolas
    [J]. BMC CANCER, 2012, 12
  • [17] Union for International Cancer Control, 2017, TNM CLASSIFICATION M, V8th
  • [18] Xynos Ioannis D, 2013, ISRN Gastroenterol, V2013, P490578, DOI 10.1155/2013/490578